Cargando…
The immune checkpoint expression in the tumor immune microenvironment of DLBCL: Clinicopathologic features and prognosis
BACKGROUND & AIMS: The immune checkpoint recently provides a new strategy for the immunotherapy of malignant tumors. However, the role in the immune microenvironment of DLBCL is not completely clear. METHODS: We detected the expression of PD-1, LAG-3, TIM-3, and TIGIT on TILs and on tumor cells...
Autores principales: | Ma, Jiajia, Pang, Xuelian, Li, Junna, Zhang, Wei, Cui, Wenli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763555/ https://www.ncbi.nlm.nih.gov/pubmed/36561512 http://dx.doi.org/10.3389/fonc.2022.1069378 |
Ejemplares similares
-
The Tumor Microenvironment of DLBCL in the Computational Era
por: Opinto, Giuseppina, et al.
Publicado: (2020) -
Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
por: Xu, Yaolin, et al.
Publicado: (2021) -
The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy
por: Russell, Bonnie L., et al.
Publicado: (2021) -
Identification of the Prognosis Value and Potential Mechanism of Immune Checkpoints in Renal Clear Cell Carcinoma Microenvironment
por: Liao, Guodong, et al.
Publicado: (2021) -
Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment
por: Chen, Peixin, et al.
Publicado: (2021)